Initial dual oral combination therapy prior to pulmonary endarterectomy (PEA) in patients with operable chronic thromboembolic pulmonary hypertension (CTEPH) and high preoperative pulmonary vascular resistance (PVR)

Y. Trigui (Marseille, France), G. Acquati (Le Kremlin-Bicêtre, France), M. Jevnikar (Le Kremlin-Bicêtre, France), D. Montani (Le Kremlin-Bicêtre, France), L. Savale (Le Kremlin-Bicêtre, France), O. Sitbon (Le Kremlin-Bicêtre, France), O. Mercier (Le Plessis Robinson, France), F. Parent (Le Kremlin-Bicêtre, France), E. Jutant (Le Kremlin-Bicêtre, France), M. Reynaud-Gaubert (Marseille, France), E. Fadel (Le Plessis Robinson, France), G. Simonneau (Le Kremlin-Bicêtre, France), M. Humbert (Le Kremlin-Bicêtre, France), X. Jais (Le Kremlin-Bicêtre, France)

Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension

Session: Chronic thromboembolic pulmonary hypertension
Session type: E-poster session
Number: 1537

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Trigui (Marseille, France), G. Acquati (Le Kremlin-Bicêtre, France), M. Jevnikar (Le Kremlin-Bicêtre, France), D. Montani (Le Kremlin-Bicêtre, France), L. Savale (Le Kremlin-Bicêtre, France), O. Sitbon (Le Kremlin-Bicêtre, France), O. Mercier (Le Plessis Robinson, France), F. Parent (Le Kremlin-Bicêtre, France), E. Jutant (Le Kremlin-Bicêtre, France), M. Reynaud-Gaubert (Marseille, France), E. Fadel (Le Plessis Robinson, France), G. Simonneau (Le Kremlin-Bicêtre, France), M. Humbert (Le Kremlin-Bicêtre, France), X. Jais (Le Kremlin-Bicêtre, France). Initial dual oral combination therapy prior to pulmonary endarterectomy (PEA) in patients with operable chronic thromboembolic pulmonary hypertension (CTEPH) and high preoperative pulmonary vascular resistance (PVR). 1537

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Initial dual oral combination therapy in inoperable chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018
Accuracy of pre-operative specimen level prediction in chronic thromboembolic pulmonary hypertension (CTEPH) patients undergoing pulmonary thromboendarterectomy (PTE) Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020
A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development Source: Eur Respir J 2003; 22: Suppl. 45, 221s Year: 2003
Long-term outcomes of pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2007; 30: Suppl. 51, 603s Year: 2007
Sequential multimodal therapy in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020
Bosentan improves 6-minutes-walk-test in patients with inoperable chronic thrombo-embolic pulmonary hypertension (iCTEPH) Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005
Mismatch of major vessel obstruction and pulmonary vascular resistance (PVR) in chronic thromboembolic pulmonary hypertension (CTEPH) with associated medical conditions (AMC) Source: Eur Respir J 2006; 28: Suppl. 50, 402s Year: 2006
Newly diagnosed patients with chronic thromboembolic pulmonary hypertension and PASP<50 mmHg. Do they need pulmonary endarterectomy? Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005
Dipyridamol as adjuvant therapy in patients with pulmonary arterial hypertension (PAH) Source: Eur Respir J 2005; 26: Suppl. 49, 562s Year: 2005
Impact of two 5-year anticoagulant strategies on survival and echocardiographic parameters in the patients with chronic thromboembolic pulmonary hypertension (CTEPH) who did not undergo pulmonary endarterectomy Source: Annual Congress 2004 - Pulmonary embolism Year: 2004
The course of chronic thromboembolic pulmonary hypertension (CTEPH) in anticoagulated patients not eligible for pulmonary endarterectomy Source: Eur Respir J 2002; 20: Suppl. 38, 237s Year: 2002
Predictive value of CT pulmonary angiography to assess surgical accessibility for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension (CTEPH) patients Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021
Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2009; 19: 64-67 Year: 2010
Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009
Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2015; 24: 263-271 Year: 2015
Balloon pulmonary angioplasty (BPA) for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018
Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension Year: 2019
Longterm survival of inoperable chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008
Patterns of therapy with sildenafil among patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010